AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

LIGAND PHARMACEUTICALS INC Director's Dealing 2020

Oct 9, 2020

31289_dirs_2020-10-09_f673d9ec-7121-4520-9c56-548245fa9f69.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pfenex Inc. (PFNX)
CIK: 0001478121
Period of Report: 2020-10-01

Reporting Person: LIGAND PHARMACEUTICALS INC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	27034437	Direct